Evidence map›Paper›PMID 37376551›Full record

Observational studyViruses2023

Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients.

Paula Fernández-Alvarez, María Fernanda Guerra-Veloz, Angel Vilches-Arenas, Patricia Cordero-Ruíz, Francisco Bellido-Muñoz, Angel Caunedo-Alvarez, Isabel Carmona-Soria

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Linked Intronic Polymorphisms of theInternational journal of molecular sciences · 2026
    Article
  2. Preventing the progression of cirrhosis to decompensation and death.Nature reviews. Gastroenterology & hepatology · 2025
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Paula Fernández-AlvarezDepartment of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.ORCID 0000-0001-9598-8768
María Fernanda Guerra-VelozDepartment of Gastroenterology and Hepatology, King's College Hospital, London SE5 9RS, UK.
Angel Vilches-ArenasDepartment of Preventive Medicine and Public Health, Faculty of Medicine, University of Seville, 41009 Seville, Spain.ORCID 0000-0003-2197-3760
Patricia Cordero-RuízDepartment of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Francisco Bellido-MuñozDepartment of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Angel Caunedo-AlvarezDepartment of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Isabel Carmona-SoriaDepartment of Gastroenterology and Hepatology, Hospital Universitario Virgen Macarena, 41009 Seville, Spain.
Hospital Universitario Virgen Macarena · ESKing's College Hospital · GBUniversidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularHepatitis CHepatitis C, ChronicHypertension, PortalLiver NeoplasmsAntiviral AgentsHepacivirusHumansLiver CirrhosisRetrospective StudiesAntiviral Agentshepatitis C virusliver fibrosisnew direct-acting antiviralsnon-invasive serum fibrosis markerssustained virological response

Identifiers

PMID37376551
PMCPMC10302896
OpenAlexW4378575582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.